Agilent SureSelect Human All Exon kit
20 November, 2009 | Agilent Technologies Australia Pty Ltd
The SureSelect Human All Exon Kit for the Applied Biosystems SOLiD System enables target enrichment prior to next-generation DNA sequencing.
Qiagen Influenza A/H1N1 test kit
20 November, 2009 | QIAGEN Pty Ltd
Qiagen has launch its Influenza A/H1N1 test and several updates to its activities in the global surveillance of the swine flu pandemic. The kit enables both the highly sensitive and specific detection of the novel Influenza A/H1N1 and all other known Influenza A and B virus strains. The test kit has been designed for use by governments and public health institutions.
Carl Zeiss LSM 780 laser scanning microscope
20 November, 2009 | ZEISS Group
Added to the LSM 7 range of laser scanning microscopes, the LSM 780 with GaAsP detector technology is claimed to significantly increase sensitivity.
Biomatrica/Qiagen QIAsafe DNA blood products
20 November, 2009 | QIAGEN Pty Ltd
Biomatrica and Qiagen have launched QIAsafe DNA Blood Products, the first dry blood storage available on a matrix based on Biomatrica’s SampleMatrix technology.
Greiner Bio-One tissue culture range
20 November, 2009 | Interpath Services Pty Ltd
Greiner Bio-One’s tissue culture products include flasks, dishes, bottles, tubes and plates. Advanced tissue culture treatments are also available.
Perkin Elmer EnSpire plate reader
20 November, 2009 | PerkinElmer (Australia) Pty Ltd
An expansion of the EnSpire Multilabel plate reader platform, EnSpire, provides users, including those working with primary or stem cells in cancer and neuropharmacology research, with improved assay performance and sensitivity.
BD Vacutainer Rapid Serum Tube
20 November, 2009 | BD
BD Diagnostics’ Preanalytical Systems has received US Food and Drug Administration (FDA) 510(k) clearance for the BD Vacutainer Rapid Serum Tube, a blood collection device designed to help acute healthcare facilities rapidly analyse blood serum for patient diagnosis.
Bio-Rad acquires Biotest diagnostics
20 November, 2009 | Bio-Rad Laboratories
Bio-Rad Laboratories has signed an agreement to acquire certain diagnostic businesses of Biotest for 45 million euros, the terms of which were not disclosed. The transaction is subject to closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2010.
Lonza Potelligent CHOK1SV host cell line
20 November, 2009 | Capsugel Australia Pty Ltd
Potelligent CHOK1SV, a host cell line for manufacturing recombinant antibodies, combines BioWa’s glycosylation Potelligent technology with Lonza’s GS Gene Expression System and CHOK1SV.
Greiner Bio-One Datamatrix Barcode Cryovials
20 November, 2009 | Interpath Services Pty Ltd
Greiner Bio-One has introduced 2D Datamatrix Cryovials for simple and accurate sample identification.
PerkinElmer AutomatedGSP Genetic Screening Processor
20 November, 2009 | PerkinElmer (Australia) Pty Ltd
PerkinElmer has received the first 510(k) clearance from the US Food and Drug Administration for its automated GSP Genetic Screening Processor, used by public health laboratories as part of newborn screening programs.
AmpFISTR Identifiler Direct, Identifiler Plus and NGM PCR Amplification Kits
20 November, 2009 | Applied Biosystems Pty Ltd
Forensic DNA kits with chemistry reagents, the AmpFISTR Identifiler Direct, Identifiler Plus and NGM PCR Amplification Kits provide good performance, efficiency and data quality, enabling fast recovery of more DNA results from a wider range of samples.
Bruker maXis, ultrafleXtreme, amaZon and solariX
20 November, 2009 | Bruker Pty Ltd
Bruker Daltonics has released its latest life science mass spectrometry tools.
Beckman Coulter Access Sex Hormone Binding Globulin (SHBG) assay
20 November, 2009 | Beckman Coulter Australia
Beckman Coulter has expanded its reproductive disease state management range with the Access Sex Hormone Binding Globulin (SHBG) assay for use in the differential diagnosis of conditions of chronic or excessive androgenic activity. The assay may also be used in conjunction with the Access Testosterone Assay to provide a calculated free androgen index1.
SensiGene Cystic Fibrosis (CF) Carrier Screening Test
20 November, 2009 | Agena Bioscience Inc
The SensiGene Cystic Fibrosis (CF) Carrier Screening Test screens for 103 mutations and five variants, including the 23 mutations recommended by the American College of Medical Genetics (ACMG).
